SANUWAVE Health, Inc.  

(Public, OTCMKTS:SNWV)   Watch this stock  
Find more results for SNWV)
-0.010 (-6.25%)
Oct 8 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.15 - 0.17
52 week 0.04 - 0.28
Open 0.17
Vol / Avg. 130,272.00/136,709.00
Mkt cap 9.46M
P/E     -
Div/yield     -
EPS -0.08
Shares 63.06M
Beta 0.61
Inst. own 25%
Nov 10, 2015
Q3 2015 SANUWAVE Health Inc Earnings Release (Estimated) Add to calendar
Aug 12, 2015
Q2 2015 SANUWAVE Health Inc Earnings Call
Aug 11, 2015
Q2 2015 SANUWAVE Health Inc Earnings Release

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin -634.02% -705.01%
Operating margin -419.52% -703.76%
EBITD margin - -665.88%
Return on average assets -201.87% -191.04%
Return on average equity - -
Employees 8 -
CDP Score - -


11475 Great Oaks Way Ste 150
ALPHARETTA, GA 30022-2482
United States - Map
+1-678-5816843 (Phone)
+1-770-4198634 (Fax)

Website links


SANUWAVE Health, Inc. (SANUWAVE) is a shockwave technology company using a system of noninvasive, acoustic shockwaves for regenerative medicine and other applications. The Company's initial focus is regenerative medicine, utilizing noninvasive, acoustic shockwaves to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal and vascular structures. Its lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers, which is in a supplemental Phase III clinical study. The Company's portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration.

Officers and directors

Kevin A. Richardson II Chairman of the Board, Co-Chief Executive Officer
Age: 46
Lisa E. Sundstrom Interim Chief Financial Officer
Age: 45
John F. Nemelka Director
Age: 49
Alan L. Rubino Independent Director
Age: 60